These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents). Vejlsgaard V; Christensen M; Clausen E Br Med J; 1967 Jun; 2(5552):598-600. PubMed ID: 6025595 [No Abstract] [Full Text] [Related]
23. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142 [TBL] [Abstract][Full Text] [Related]
25. [Experiences with a new antihypertensive agent (Tadip)]. Becker L Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817 [No Abstract] [Full Text] [Related]
26. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO]. Mayer K; Lupínek Z; Janousek S; Podrouzková B Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673 [No Abstract] [Full Text] [Related]
27. Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality. Singer RB J Insur Med; 1992; 24(1):28-31. PubMed ID: 10148474 [No Abstract] [Full Text] [Related]
28. [Therapeutic effects of debrisoquine sulfate in hypertension]. Liu HW; Chen CY Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):189-95. PubMed ID: 4506851 [No Abstract] [Full Text] [Related]
29. [Hypotensive drugs]. Cybulska I Pol Arch Med Wewn; 1979 Nov; 62(5):437-47. PubMed ID: 43505 [No Abstract] [Full Text] [Related]
30. No evidence that treatment of hypertension does not explain much of the decline in mortality from stroke in New Zealand. Simpson FO N Z Med J; 1987 Jul; 100(828):452-3. PubMed ID: 3451124 [No Abstract] [Full Text] [Related]
31. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate]. Chiummo R Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408 [TBL] [Abstract][Full Text] [Related]
32. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension]. Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915 [No Abstract] [Full Text] [Related]
33. An approach to the medical treatment of hypertension in the aged. Vidt DG Geriatrics; 1969 Apr; 24(4):120-9. PubMed ID: 5774576 [No Abstract] [Full Text] [Related]
34. [New antihypertensive drugs. II. Debrisoquin or Declinax]. Amery A; Deruyttere M; Fagard R; Koninckx P Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889 [No Abstract] [Full Text] [Related]
35. [Antihypertensive therapy as stroke prevention also in elderly people?]. Eisenblätter D; Ihle E Z Gesamte Inn Med; 1973 Jul; 28(14):Suppl:224 c. PubMed ID: 4728096 [No Abstract] [Full Text] [Related]
36. Hypertension and stroke. Cooper RS J Hypertens; 1995 Feb; 13(2):277-8. PubMed ID: 7615960 [No Abstract] [Full Text] [Related]
37. Antihypertensive therapy before, during, and after stroke. Mzimba ZS; Beevers DG; Lip GY Basic Res Cardiol; 1998; 93 Suppl 2():59-62. PubMed ID: 9833165 [TBL] [Abstract][Full Text] [Related]
38. Hypertension and cerebrovascular disease. Bansal BC; Agarwal AK; Rewari BB J Indian Med Assoc; 1999 Jun; 97(6):226-32. PubMed ID: 10645696 [TBL] [Abstract][Full Text] [Related]
39. Debrisoquine sulphate--a new antihypertensive agent with minimal side-effects. Chen BT Singapore Med J; 1971 Apr; 12(2):106-9. PubMed ID: 4945291 [No Abstract] [Full Text] [Related]
40. Antihypertensive drugs in the treatment of hypertension. Louis WJ Drugs; 1972; 4(1):90-100. PubMed ID: 4404680 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]